Japan, Aug. 31 -- OCUPHIRE PHARMA INC has got intellectual property rights for 'METHODS AND COMPOSITIONS FOR TREATMENT OF PRESBYOPIA, MYDRIASIS, AND OTHER OCULAR DISORDERS.' Other related details are as follows:
Application Number: JP,2024-192561
Category (FI): A61K47/26,A61K47/10,A61K47/12,A61P27/10,A61P27/06,A61K9/08,A61P43/00,111,A61K31/417,A61P27/02
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Nov. 1, 2024
Publication Date: March 11, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
